Company profile

Saranas Inc.

Saranas Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on May 25, 2023 and the most recent on May 25, 2023 (Saranas Early Bird Bleed Monitoring System). Its most common review panel is Cardiovascular (1 device).

1AI devices

2023First decision

2023Latest decision

1Specialties

Timeline

May 25, 2023 · 510(k) K230273Saranas Early Bird Bleed Monitoring System · Cardiovascular · QFJ